Heme Oxygenase-Derived Carbon Monoxide Restores Vascular Function in Type 1 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|2|4|290-300

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.2, Iss.4, 2008-12, pp. : 290-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1370-1391

Bentham Science Publishers

Access to resources Recommend Favorite

The Heme Oxygenase System and Type-1 Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1328-1337

Bentham Science Publishers

Access to resources Recommend Favorite

Where is the Clinical Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics?

By  

Current Pharmaceutical Design, Vol. 24, Iss. 20, 2018-06 ,pp. : 2264-2282

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury

By  

Current Pharmaceutical Design, Vol. 23, Iss. 26, 2017-10 ,pp. : 3884-3898

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1/Carbon Monoxide: Novel Therapeutic Strategies in Critical Care Medicine

By  

Current Drug Targets, Vol. 11, Iss. 12, 2010-12 ,pp. : 1485-1494

Bentham Science Publishers

Access to resources Recommend Favorite